Senseonics Holdings, Inc. (SENS) AMEX

0.70

+0.0143(+2.07%)

Updated at May 08 10:41AM

Currency In USD

Senseonics Holdings, Inc.

Address

20451 Seneca Meadows Parkway

Germantown, MD 20876-7005

United States of America

Phone

301 515 7260

Sector

Healthcare

Industry

Medical - Devices

Employees

117

First IPO Date

December 22, 2015

Key Executives

NameTitlePayYear Born
Dr. Timothy T. Goodnow Ph.D.President, Chief Executive Officer & Director1.27M1962
Mr. Kenneth L. Horton J.D.General Counsel & Corporate Development Advisor750,7121967
Dr. Mukul Jain Ph.D.Chief Operating Officer902,9201973
Dr. Francine Ratner Kaufman M.D.Chief Medical Officer & Director01952
Mr. Frederick T. Sullivan CPAChief Financial Officer, Secretary & Treasurer01982

Description

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.